Medicine
Long Island Man Sebastien Beauzile Becomes First New Yorker Cured of Sickle Cell Disease With Lyfgenia Gene Therapy
Health News
mars 14, 2025
Long Island Man Sebastien Beauzile Becomes First New Yorker Cured of Sickle Cell Disease With Lyfgenia Gene Therapy
Sebastien Beauzile, 21, received Lyfgenia at Cohen Children's Medical Center and is free of sickle cell pain. The $3.1 million therapy still reaches only a handful of patients.
Cancer Drugs Targeting IDO1 And Approved Antibody Kisunla Offer Separate Paths For People Facing Early Alzheimer’s Disease
Health News
août 22, 2024
Cancer Drugs Targeting IDO1 And Approved Antibody Kisunla Offer Separate Paths For People Facing Early Alzheimer’s Disease
Eli Lilly's Kisunla won FDA approval on July 2, 2024, an EU authorization in September 2025, and a slower-titration label in July 2025 that cut ARIA-E. A 2024 Science paper…